文献速递头颈MR

4D动态对比增强MRI用于原发性甲状旁腺功能亢进患者术前定位

4D-Dynamic Contrast-Enhanced MRI for Preoperative Localization in Patients with Primary Hyperparathyroidism.
PubMed 文献 · AJNR Am J Neuroradiol · 2020-03-12

本研究纳入54例生化确诊原发性甲状旁腺功能亢进且术后治愈的患者,评估高空间与时间分辨率4D动态对比增强MRI对术前腺体定位的准确性。单腺病正确腺体定位34/37(92%),多腺病35/47(74%),观察者间侧别一致性κ单腺病0.92、多腺病0.70。作者结论认为该技术诊断性能优异,优于4D-CT研究。

要点

  • 4D动态对比增强MRI对单腺病腺体定位准确34/37(92%),侧别识别37/37(100%),象限识别34/37(92%)。
  • 多腺病腺体定位准确35/47(74%),侧别35/47(74%),象限36/47(77%)。
  • 观察者间侧别一致性单腺病κ=0.92、多腺病κ=0.70;象限一致性单腺病κ=0.70、多腺病κ=0.69。

核心结论

  • 作者结论:所提出的高空间与时间分辨率4D动态对比增强MRI对原发性甲状旁腺功能亢进术前定位具有优异诊断性能,单腺病正确腺体定位92%、多腺病74%,优于4D-CT研究。

研究设计与样本

  • 研究类型为影像诊断准确性研究,纳入54例符合标准的患者,均经生化确诊原发性甲状旁腺功能亢进、术前行4D动态对比增强MRI、术中血清甲状旁腺激素下降>50%达到手术治愈。
  • 4D动态对比增强MRI由2名神经放射科医师独立阅片,识别异常腺体的侧别、象限和数目,并与手术及病理结果对照。

诊断标准与关键数值

  • 单腺病:正确腺体定位34/37(92%),侧别正确37/37(100%),象限正确34/37(92%)。
  • 多腺病:正确腺体定位35/47(74%),侧别正确35/47(74%),象限正确36/47(77%)。
  • 观察者间一致性κ:侧别单腺病0.92、多腺病0.70;象限单腺病0.70、多腺病0.69。
  • 患者构成:37例单腺病,17例多腺病(9例双腺增生、3例3腺增生、5例4腺增生)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Our aim was to test the hypothesis that our recently introduced 4D-dynamic contrast-enhanced MR imaging with high spatial and temporal resolution has equivalent accuracy to 4D-CT for preoperative gland localization in primary hyperparathyroidism without requiring exposure to ionizing radiation.

MATERIALS AND METHODS: Inclusion criteria were the following: 1) confirmed biochemical diagnosis of primary hyperparathyroidism, 2) preoperative 4D-dynamic contrast-enhanced MR imaging, and 3) surgical cure with >50% decrease in serum parathyroid hormone intraoperatively. 4D-dynamic contrast-enhanced studies were reviewed independently by 2 neuroradiologists to identify the side, quadrant, and number of abnormal glands, and compared with surgical and pathologic results.

RESULTS: Fifty-four patients met the inclusion criteria: 37 had single-gland disease, and 17, multigland disease (9 with double-gland hyperplasia; 3 with 3-gland hyperplasia; and 5 with 4-gland hyperplasia). Interobserver agreement (κ) for the side (right versus left) was 0.92 for single-gland disease and 0.70 for multigland disease. Interobserver agreement for the quadrant (superior versus inferior) was 0.70 for single-gland disease and 0.69 for multigland disease. For single-gland disease, the gland was correctly located in 34/37 (92%) patients, with correct identification of the side in 37/37 (100%) and the quadrant in 34/37 (92%) patients. For multigland disease, the glands were correctly located in 35/47 (74%) patients, with correct identification of the side in 35/47 (74%) and the quadrant in 36/47 (77%).

CONCLUSIONS: The proposed high spatial and temporal resolution 4D-dynamic contrast-enhanced MR imaging provides excellent diagnostic performance for preoperative localization in primary hyperparathyroidism, with correct gland localization of 92% for single-gland disease and 74% in multigland disease, superior to 4D-CT studies.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Becker JL, Patel V, Johnson KJ, et al. 4D-Dynamic Contrast-Enhanced MRI for Preoperative Localization in Patients with Primary Hyperparathyroidism. AJNR Am J Neuroradiol. 2020. PMID: 32165367. doi:10.3174/ajnr.A6482

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。